Sutro Biopharma, Inc 10-Q for FY2023 Q3
Sutro Biopharma, Inc. (STRO)
10-Q
2023-11-13
For: 2023-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on November 13, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $16.92M
- down 32.7% from $25.15M a year earlier
- Net loss
- $49.28M
- compared with a net loss of $19.49M a year earlier
- Diluted EPS
- -$0.81
- compared with -$0.37 a year earlier